Opportunity timeline
In plain English
The CDC plans to award a sole-source, fixed-price contract to Cayman Chemical Company for the Emergent Drug Panel-Version 2 Kit and continued support for existing EDP kits. Work includes designing and manufacturing kits, maintaining required DEA status, nationwide distribution to approved laboratories, customer support, usage reporting, and stability testing. The expected performance period is September 30, 2026, through September 29, 2027, with four option years. Vendors that can perform this work may email capability information or a response to the contracting officer by 11:00 a.m. ET on September 14, 2026; this is not a competitive request for quotations.
About this opportunity
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Cayman Chemical Company, Inc. for the design, manufacture, distribution, and associated laboratory support services for the Emergent Drug Panel-Version 2 (EDP-V2) Kit, a new product line addition within CDC's Traceable Opioid Material (TOM®) Kit program, and continued distribution, product support, and data collection services for existing Emergent Drug Panel (EDP) Kit products. The anticipated period of performance is 09/30/2026 through 09/29/2027. The requirement will include four option years for design and manufacture of additional kits as well as continuous distribution. The…
Time remaining
Closes Sep 14, 2026
Related Opportunities

Illumina DRAGEN Tier 3 Throughput License and v4 Server

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Health Advisory Committees Research and Support

N66001-26-R-0030 - Academic Research MAC
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-57C76F

